Evidence map›Paper›PMID 33196122›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2021

Quantitative analysis of mitochondrial membrane potential heterogeneity in unsynchronized and synchronized cancer cells.

Amandine Rovini, Kareem Heslop, Elizabeth G Hunt, Morgan E Morris, Diana Fang, Monika Gooz, Akos A Gerencser, Eduardo N Maldonado

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Amandine RoviniDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA.
Kareem HeslopDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA.
Elizabeth G HuntDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA.
Morgan E MorrisDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA.
Diana FangDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA.
Monika GoozDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA.
Akos A GerencserBuck Institute for Research on Aging and Image Analyst Software, Novato, CA, USA.
Eduardo N MaldonadoDepartment of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA.
Medical University of South Carolina · USBuck Institute for Research on Aging · US

Funding

SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20GM103542 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2012 to 2020
$20.2M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
MUSC Minority Student Development ProgramR25GM072643 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ERGUL, ADVIYE, RINKER, JENNIFER ANNE · 2005 to 2023
$5.8M
MUSC Post-Baccalaureate Research Education ProgramR25GM113278 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DELEON-PENNELL, KRISTINE Y, PENROD-MARTIN, RACHEL · 2015 to 2024
$2.7M
VDAC-Tubulin Regulation of Mitochondrial Membrane Potential HeterogeneityR01CA184456 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MALDONADO, EDUARDO NESTOR · 2016 to 2020
$1.9M
NCI NIH HHS R01 CA184456NIDDK NIH HHS P30 DK123704NIGMS NIH HHS P20 GM103542NIGMS NIH HHS R25 GM072643NIGMS NIH HHS R25 GM113278
6 · The paper itself

Abstract

Mitochondrial membrane potential (ΔΨm) is a global indicator of mitochondrial function. Previous reports on heterogeneity of ΔΨm were qualitative or semiquantitative. Here, we quantified intercellular differences in ΔΨm in unsynchronized human cancer cells, cells synchronized in G1, S, and G2, and human fibroblasts. We assessed ΔΨm using a two-pronged microscopy approach to measure relative fluorescence of tetramethylrhodamine methyl ester (TMRM) and absolute values of ΔΨm. We showed that ΔΨm is more heterogeneous in cancer cells compared to fibroblasts, and it is maintained throughout the cell cycle. The effect of chemical inhibition of the respiratory chain and ATP synthesis differed between basal, low and high ΔΨm cells. Overall, our results showed that intercellular heterogeneity of ΔΨm is mainly modulated by intramitochondrial factors, it is independent of the ΔΨm indicator and it is not correlated with intercellular heterogeneity of plasma membrane potential or the phases of the cell cycle.

Indexed as

Cell CycleMembrane Potential, MitochondrialHep G2 CellsHumansMitochondriaMitochondrial MembranesNeoplasmscancercell cyclefibroblastsHepG2 cellsheterogeneitymitochondriamitochondrial membrane potentialplasma membrane potentialTMRM

Identifiers

PMID33196122
PMCPMC7871195
OpenAlexW3105015899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.